Y-mAbs Therapeutics, Inc.

CIK 1722964 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Y-mAbs Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2025SCHEDULE 13G/A0000902664-25-004973
Nov 14, 2025SCHEDULE 13G/A0000935836-25-000695
Nov 14, 2025SCHEDULE 13G/A0001104659-25-112490
Nov 14, 2025SCHEDULE 13G/A0001104659-25-112618
Nov 13, 2025SCHEDULE 13G/A0001076809-25-000139
Sep 26, 202515-12G0001104659-25-093587
Sep 19, 202540001751804-25-000004
Sep 18, 202540001753231-25-000004
Sep 18, 202540001732197-25-000005
Sep 18, 202540001948795-25-000004
Sep 18, 202540001585839-25-000004
Sep 18, 202540001753193-25-000004
Sep 18, 202540001245624-25-000004
Sep 18, 202540001106519-25-000005
Sep 18, 202540001753185-25-000004
Sep 18, 202540001752467-25-000005
Sep 18, 202540002052524-25-000003
Sep 18, 202540001753224-25-000004
Sep 16, 2025S-8 POS0001104659-25-090244
Sep 16, 2025S-8 POS0001104659-25-090237
Sep 16, 202525-NSE0001354457-25-000904
Sep 16, 2025POS AM0001104659-25-090236
Sep 16, 20258-K0001104659-25-090232
Sep 16, 2025S-8 POS0001104659-25-090238
Sep 16, 2025EFFECT9999999995-25-002969